FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.350
0.00 (0.00%)
At close: Nov 20, 2024, 4:00 PM
0.336
-0.014 (-4.00%)
Pre-market: Nov 21, 2024, 4:02 AM EST
FibroGen Market Cap
FibroGen has a market cap or net worth of $35.27 million as of November 21, 2024. Its market cap has decreased by -35.87% in one year.
Market Cap
35.27M
Enterprise Value
39.21M
1-Year Change
-35.87%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $35.27M, a decrease of -97.12%. That is a compound annual growth rate of -29.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 35.30M | -59.47% |
| Dec 29, 2023 | 87.10M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 36.10M |
| DIH Holding US | 36.08M |
| Barinthus Biotherapeutics | 35.72M |
| OS Therapies | 35.50M |
| Adagio Medical Holdings | 35.47M |
| OKYO Pharma | 34.85M |
| Citius Pharmaceuticals | 34.66M |
| Iterum Therapeutics | 34.51M |